No insider purchase over the last 90 days. The latest was filed 06 Jun 2024.
Lifecare ASA belongs to the Health Care sector. Filings by its managers are published through Oslo Børs. Over the twelve months to 18 October 2026, 23 filings were filed, from 8 insiders.
All open-market trades in the period are sales: 8 sales worth €1.6M, by 5 insiders, with no purchase on record. The amount is not disclosed for 4 filings. Biggest ticket of the year: €1.3M, sold by Contacts For and made public on 19 May 2026 (10.8% of market cap).
Filings reach the Oslo Børs feed a median of 1 day after the trade. Under the Market Abuse Regulation, managers have three business days to notify their trades. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning.
Across the 258 companies tracked on its exchange, the median is 4 filings; at 23 filings, this issuer sits above that mark. The full history, which starts in 2021, counts 2 purchases against 12 sales.
Elsewhere in the same sector, our signals recently picked up insider purchases at Anixa Biosciences Inc and Vivos Inc. Source: insider filings from Oslo Børs. Past trades are no guide to future returns.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
FY ended December 2025 · cache
25 of 42 declarations
Lifecare ASA is a Norwegian company focused on developing health solutions and medical devices. It is listed on the XOSL exchange.
Purchases our model currently ranks for the recommendations list.
All recommendations